Navigation Links
Generation of a severe memory-deficit mutant mouse by exclusively eliminating the kinase activity of CaMKIIalpha
Date:6/19/2009

Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) is an enzyme that adds phosphates to a variety of protein substrates to modify their functions. CaMKII alpha is enriched in the hippocampus, the memory center of the brain, and is believed to be an essential mediator of activity-dependent synaptic plasticity and memory functions. However, the causative role of the enzymatic activity of CaMKII alpha in such processes has not been demonstrated yet, because this enzyme has multiple protein functions other than the kinase activity. A Japanese research group, led by Dr Yoko Yamagata of the National Institute for Physiological Sciences, Japan, has successfully generated a novel kinase-dead mutant mouse of the CaMKII alpha gene that completely and exclusively lacks its kinase activity. They examined hippocampal synaptic plasticity and behavioral learning of the mouse, and found a severe deficit in both processes. They reported their findings in the Journal of Neuroscience, published on June 10, 2009.

The research group successfully generated a novel CaMKII alpha (K42R) knock-in mouse that completely lacks the kinase activity of CaMKII alpha, and examined the effects on structural, functional, and behavioral expression of synaptic memory. In the K42R brain, tetanus-induced long-term potentiation (LTP), a proposed cellular mechanism of memory, and sustained postsynaptic spine enlargement, a structural basis for LTP, were both impaired, whereas dynamic postsynaptic movement of CaMKII alpha protein was preserved. In addition, the K42R mouse showed a severe deficit in inhibitory avoidance learning, a form of memory dependent on the hippocampus. The research group concluded that the mutant mouse could not form memories and did not remember the events that had just happened.

"We demonstrated that the mutant mouse has a severe memory deficit because of the lack of the kinase activity of CaMKII alpha. This finding supports the idea that
'/>"/>

Contact: Dr. Yoko Yamagata
yamagata@nips.ac.jp
81-564-595-887
National Institute for Physiological Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Next Generation Waters - Nuu
2. Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
3. Abbott Announces Launch of Next-Generation Embolic Protection System
4. Purity Products Partners with Leading Vitamin D Expert to Create Next-Generation D3 Complex
5. San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations
6. RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment
7. Nonin Medical Introduces Next-Generation Regional Oximeter at Euroanaesthesia 2009
8. ZigBee Selected by Continua Health Alliance for Next Generation Guidelines
9. Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution
10. First heart patients implanted with next-generation mechanical heart pump
11. AARP to Host Cross-Generational Life Festival in Chicago, June 5-6

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...very preterm births more likely, British study fin...-- Pregnant women who are poor are more likely to ...en, even though both groups typically receive equa...sity of Leicester research team said their finding...n between economic status and preterm birth. , ...
(Date:12/1/2009)...RLEANS, Dec. 1 The Amer...ual High School Student Symposium at the New Orlea...CST. The symposium, which encourages an interest i... research, is held in conjunction with the Society...ave the opportunity to explore research on sickle ...
(Date:12/1/2009)...NGTON, Dec. 1 On Decemb... 1,538 federal prisoners were HIV positive or had ...BJS) in the Office of Justice Programs, U.S. Depar..., an estimated 5,672 inmates in state and federal ...7. In 2007, about 43 per 10,000 prison inmates wer...
(Date:12/1/2009)...ho would benefit from liver surgery after chemo, s...Day News) -- A CT scan of liver tumors caused by t...erall survival after chemotherapy, researchers rep...c chemotherapy has been shown to improve survival ...to produce better results in patients having surge...
(Date:12/1/2009)... Practitioners of any medical, legal or busines...ing a sigh of relief this week with the release of...on, released over the holiday weekend, allows anyo...ings to do so quickly and seamlessly using just th...WEB) December 1, 2009 -- The iPhone App, released ...
Breaking Medicine News(10 mins):Health News:More Preemies Born Among the Poor 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2
...rchers at the Genomics Institute of the Novartis R...compounds that can trigger the proliferation of i...isticated high-throughput screening techniques. ...the first study of its kind, and represents an imp...
...k factor is metabolic syndrome has distinct forms ...se findings are in the March issue of Hepatology ...lf of the American Association for the Study of Li...s hepatocellular carcinoma, is the fifth most comm...
... Spinal Association ( www.UnitedSpinal.org ) and i...First.org ), in partnership with Vietnam Veterans ...s Health Council ( www.veteranshealth.org ) at a ...onal forum for health care professionals, advocacy...
...in Diabetes Prevention and Management Among Most A...erck Company Foundation (Foundation), the philanth...d the launch of The Alliance to Reduce Disparities...n, Hispanic, and Native American adults. The U.S....
...rcent of Patients Select OTC Products Recommended ...hington, D.C. (Vocus) February 25, 2009 -- Accordi...ter Product Survey conducted by the American Phar...cist. With more than 100,000 nonprescription medic...
... Getaways ... Exclusive Couture Creations and Pack...ralysis , , BAL HARBOUR, Fla., Feb. 25 South Fl...ashion,s top designers and the highest concentrati...tion that kicks off on Thursday, February 26, be...
Other Medicine News:Health News:Compounds that trigger beta cell replication identified by JDRF funded researchers 2Health News:Liver tumors associated with metabolic syndrome differ from other tumors 2Health News:United Spinal Association Introduces The Veterans Health Council: Improving Veterans Health through Information and Advocacy 2Health News:United Spinal Association Introduces The Veterans Health Council: Improving Veterans Health through Information and Advocacy 3Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 2Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 3Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 4Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 5Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 6Health News:Pharmacists Encourage Patients To Seek Their Guidance When Choosing OTC Medications 2Health News:Spectacular Ultra-Luxe Auction for Destination Fashion 2009, Presented by Stewart Rahr, Best of Bal Harbour's Brands Contribute More Than $250,000 Worth of Exclusive Items 2Health News:Spectacular Ultra-Luxe Auction for Destination Fashion 2009, Presented by Stewart Rahr, Best of Bal Harbour's Brands Contribute More Than $250,000 Worth of Exclusive Items 3Health News:Spectacular Ultra-Luxe Auction for Destination Fashion 2009, Presented by Stewart Rahr, Best of Bal Harbour's Brands Contribute More Than $250,000 Worth of Exclusive Items 4
(Date:12/1/2009)... 1 MedNet Solutions, a global life...g in clinical study management systems, today anno... EDC/eClinical technology solution, has been certi...nsortium (CDISC) as complying with the Operational...derscores MedNet,s commitment to streamlining the ...
(Date:12/1/2009)...APOLIS, Dec. 1 The educa... Health... Improving Life," created by Lilly USA (...tterhealth.com/value_of_medicine.jsp . The booklet... That Matter" and encourages an open dialogue with...pharmaceutical industry practices. ,, "Today, ...
(Date:12/1/2009)... 1 SCOLR Pharma, Inc. (N...09 it licensed to Chrono Nutraceuticals LLC exclus...extended release dietary supplements using SCOLR,s... addition, SCOLR granted Chrono rights to manufact...ates on a nonexclusive basis. Chrono paid SCOLR $...
Breaking Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 1QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 2QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 3QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 4InSound Medical Kicks Off 26quot 3BTell Us Your Story 26quot 3B Contest 57289 1InSound Medical Kicks Off 26quot 3BTell Us Your Story 26quot 3B Contest 57289 2Community Mitigation Lessons From Mexicos A 28H1N1 29 Response 57286 1Community Mitigation Lessons From Mexicos A 28H1N1 29 Response 57286 2Community Mitigation Lessons From Mexicos A 28H1N1 29 Response 57286 3
..., Calif., June 10 /PRNewswire-FirstCall/ - Neuroge...pany focused on developing and,commercializing nov...publication of Phase 3 data of its lead product ca...aper, titled, "Controlled Trial in,High-Concentrat...europathy," will appear in the June 10, 2008 editi...
...rial Results Expected in Q3 2008, Conference Call...astern Time, MOU..., Inc. (Nasdaq: ALXA ) announced today that it ha...al trial with AZ-004 (Staccato(R),loxapine). AZ-00...ed for,the treatment of acute agitation in patient...
Other Medicine Technology:NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 2NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7
Reliavac® 400ccEvacuators & Kits
Reliavac® 100cc low suction evacuator kits with flat drains and Y-connector tubing
Bile Bags
Whelan-Moss T-Tube
Medicine Products: